Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.47 [0.29-0.75],0.00142789567478806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS4,Galectin-4,Inverse variance weighted,4,1.26 [1.09-1.46],0.0014335420372764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS9,Galectin-9,Inverse variance weighted,26,1.08 [1.03-1.13],0.00228931003985895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VWC2,Brorin,Inverse variance weighted,22,1.1 [1.03-1.18],0.00449937866848807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.09 [1.02-1.17],0.00855937656156615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VGF,Neurosecretory protein VGF,Wald ratio,1,0.44 [0.23-0.82],0.0104816647799781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPON2,Spondin-2,Inverse variance weighted,4,1.14 [1.03-1.26],0.0109958588293334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.09 [1.02-1.17],0.0118770565740164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGA4,Pepsin A-4,Inverse variance weighted,2,1.48 [1.09-2.01],0.013159223663238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.14 [1.03-1.27],0.0135197057159793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.07 [1.01-1.12],0.0159853634963414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.89 [0.82-0.98],0.0171019925986161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.89 [0.8-0.98],0.0231628137811592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PALM2,Paralemmin-2,Inverse variance weighted,8,1.11 [1.01-1.22],0.0259071217919229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,UMOD,Uromodulin,Inverse variance weighted,29,1.03 [1-1.06],0.0265574013734978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.85 [0.73-0.98],0.0275480372241581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.09 [1.01-1.18],0.0293543369354882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.04 [1-1.08],0.0304578214709495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCG2,Secretogranin-2,Wald ratio,1,0.6 [0.37-0.98],0.0403768187224846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.15 [1.01-1.32],0.0419196375438082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DSC2,Desmocollin-2,Inverse variance weighted,9,0.92 [0.85-1],0.0425914281359603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.2 [1-1.43],0.0442001542980607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.56 [0.31-0.99],0.0474636387166275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.87 [0.76-1],0.047522906303664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.97 [0.93-1],0.0480383288364773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.95 [0.91-1],0.050048982205056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.94 [0.89-1],0.0521468672535728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.59 [0.34-1.01],0.0526690110732134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ELN,Elastin,Inverse variance weighted,2,0.74 [0.55-1.01],0.0542883977455672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CST3,Cystatin-C,Inverse variance weighted,10,1.08 [1-1.16],0.0546550705271753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.7 [0.48-1.01],0.0560610609910863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSL,Cathepsin L1,Wald ratio,1,1.63 [0.99-2.71],0.0563122641822634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.86 [0.74-1],0.0565248326969162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.15 [1-1.32],0.0577049194064364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1.03 [1-1.07],0.0602901706077673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PALM,Paralemmin-1,Inverse variance weighted,6,0.89 [0.8-1],0.0605540511385138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLK11,Kallikrein-11,Inverse variance weighted,6,0.94 [0.89-1],0.0648662606545446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.12 [0.99-1.26],0.0701530097545171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.03 [1-1.07],0.0777677071923574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.05 [0.99-1.11],0.0817483993532515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BSG,Basigin,Wald ratio,1,1.16 [0.98-1.37],0.0867862681846358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.94 [0.87-1.01],0.0882231641707902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.05 [0.99-1.1],0.0901612009919492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.94 [0.88-1.01],0.0904938770777767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.16 [0.97-1.37],0.097418719393497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH6,Cadherin-6,Inverse variance weighted,29,1.04 [0.99-1.08],0.0981021003872282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,0.95 [0.89-1.01],0.0993263850174225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.93 [0.84-1.01],0.0997938322488126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.94 [0.88-1.01],0.106703134180118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.89 [0.78-1.03],0.108210895544416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.94 [0.88-1.01],0.109745964271593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.95 [0.88-1.01],0.11047181184797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MB,Myoglobin,Wald ratio,1,1.64 [0.89-3.05],0.115762292643267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRSS2,Trypsin-2,Inverse variance weighted,3,1.13 [0.97-1.31],0.116094681239258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.95 [0.89-1.01],0.118583656987537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.13 [0.97-1.33],0.119203893311459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.11 [0.97-1.26],0.120529919042858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.19 [0.95-1.48],0.121953941987618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,1.1 [0.98-1.23],0.123680421678949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.19 [0.95-1.48],0.124529154917031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.06 [0.98-1.14],0.125663692464286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSV,Cathepsin L2,Inverse variance weighted,11,0.94 [0.86-1.02],0.126813509229509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.04 [0.99-1.08],0.127507726901818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.14 [0.96-1.36],0.135094207990984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.92 [0.81-1.03],0.138199544155696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.86 [0.71-1.05],0.138937133012987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.86 [0.71-1.05],0.146162612076411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.91 [0.8-1.03],0.146195381056041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OGN,Mimecan,Inverse variance weighted,30,0.96 [0.9-1.02],0.150057240149896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP6,Gastrotropin,Wald ratio,1,0.88 [0.74-1.05],0.151361945383476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALB2,Calretinin,Wald ratio,1,1.32 [0.9-1.92],0.151863958781597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RETN,Resistin,Inverse variance weighted,9,0.97 [0.92-1.01],0.153376409477355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN3,CCN family member 3,Inverse variance weighted,19,0.95 [0.89-1.02],0.157578980288915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPP1,Osteopontin,Inverse variance weighted,8,0.87 [0.72-1.06],0.161379837956872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH3,Cadherin-3,Inverse variance weighted,2,1.21 [0.92-1.59],0.163654033365988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.96 [0.91-1.02],0.165324467011992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.06 [0.97-1.16],0.16795839305389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRSS8,Prostasin,Inverse variance weighted,5,0.89 [0.76-1.05],0.167987204536607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH15,Cadherin-15,Inverse variance weighted,18,0.96 [0.91-1.02],0.175688606096017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.9 [0.77-1.05],0.178275410991358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD46,Membrane cofactor protein,Wald ratio,1,0.84 [0.64-1.09],0.179762968666782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEPTIN8,Septin-8,Inverse variance weighted,2,0.88 [0.73-1.06],0.183667485801241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.09 [0.96-1.23],0.186250619688687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.09 [0.96-1.23],0.187494383682344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.9 [0.77-1.05],0.189267145996285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.05 [0.98-1.12],0.200028523661316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,1.07 [0.97-1.18],0.204159378478395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.97 [0.92-1.02],0.21039258865081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.05 [0.97-1.12],0.215694731343957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.03 [0.98-1.07],0.221445091357418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.98 [0.95-1.01],0.223430370599301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.97 [0.92-1.02],0.226538295428222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.05 [0.97-1.15],0.238423285188471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.05 [0.97-1.13],0.242242164934679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.96 [0.88-1.03],0.242357411411368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.88 [0.71-1.09],0.247577296687966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.71 [0.4-1.27],0.250518274145352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.97 [0.92-1.02],0.259347281439573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.9 [0.74-1.08],0.259791738310486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.03 [0.98-1.08],0.26082451669951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,0.97 [0.93-1.02],0.260909077860495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COLEC12,Collectin-12,Inverse variance weighted,11,0.94 [0.84-1.05],0.266349798605857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LMNB2,Lamin-B2,Wald ratio,1,1.38 [0.78-2.46],0.268585773246629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.02 [0.99-1.05],0.272896811456503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.02 [0.98-1.07],0.277312646817276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,3,0.92 [0.79-1.07],0.27950094830763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RGMB,RGM domain family member B,Inverse variance weighted,9,0.93 [0.83-1.06],0.288688234699239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.12 [0.9-1.39],0.296585519174945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NRP2,Neuropilin-2,Inverse variance weighted,11,0.96 [0.88-1.04],0.298478381868751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.1 [0.92-1.3],0.299599477777486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.05 [0.96-1.14],0.30430227954753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD276,CD276 antigen,Inverse variance weighted,20,1.02 [0.98-1.06],0.307781284770188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.02 [0.99-1.05],0.308623067930181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.17 [0.87-1.57],0.310120232896017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.98 [0.94-1.02],0.310904122754167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.03 [0.98-1.08],0.312950486041229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.97 [0.93-1.02],0.313594104439856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,0.76 [0.44-1.3],0.316273632801928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.94 [0.83-1.06],0.318396538707872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDH12,Protocadherin-12,Inverse variance weighted,13,1.03 [0.97-1.1],0.319929206385444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.09 [0.92-1.28],0.325866564395136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.86 [0.63-1.17],0.32763715215106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.15 [0.87-1.51],0.334054854226453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.06 [0.94-1.18],0.336167835429627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.03 [0.97-1.09],0.336803507171324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.84 [0.59-1.2],0.338352538936567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DRAXIN,Draxin,Inverse variance weighted,13,1.02 [0.98-1.07],0.338894836793576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CX3CL1,Fractalkine,Inverse variance weighted,9,0.94 [0.83-1.07],0.342596362479739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL17C,Interleukin-17C,Inverse variance weighted,3,0.88 [0.67-1.15],0.343162751707175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.26 [0.77-2.08],0.353481600369215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.9 [0.73-1.12],0.360584088732148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.01 [0.98-1.05],0.36229648716881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.06 [0.93-1.2],0.362598779888472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.97 [0.9-1.04],0.367598299899619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.05 [0.94-1.18],0.370721915011692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NECTIN2,Nectin-2,Inverse variance weighted,5,0.97 [0.91-1.04],0.371730005602008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.84 [0.57-1.23],0.373338886514772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.95-1.02],0.376847647243986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.04 [0.95-1.14],0.377670649912034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.05 [0.95-1.16],0.377726439657815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GUCA2A,Guanylin,Inverse variance weighted,9,0.95 [0.84-1.07],0.378862014483196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ALCAM,CD166 antigen,Inverse variance weighted,6,0.93 [0.79-1.1],0.382932954277067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.07 [0.91-1.27],0.39039966577901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.93 [0.79-1.09],0.393159897896641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.06 [0.93-1.21],0.396406544157418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.02 [0.98-1.06],0.399839728690796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.06 [0.93-1.21],0.402072282325512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAYN,Layilin,Inverse variance weighted,20,0.97 [0.91-1.04],0.414375698380784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.05 [0.94-1.16],0.417373186246595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AMBP,Protein AMBP,Inverse variance weighted,3,1.06 [0.91-1.24],0.425221510249162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL19,Interleukin-19,Inverse variance weighted,11,1.03 [0.96-1.1],0.426875472078896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.96 [0.88-1.06],0.427069161677088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TMSB10,Thymosin beta-10,Wald ratio,1,1.17 [0.79-1.75],0.42854188159618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.06 [0.92-1.21],0.430601477055049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.07 [0.91-1.25],0.432399533002761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.04 [0.94-1.15],0.438012557167707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.06 [0.91-1.23],0.440170715011969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.94 [0.82-1.09],0.44411788190066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.1 [0.86-1.39],0.444491950101652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDHR1,Cadherin-related family member 1,Inverse variance weighted,9,1.02 [0.97-1.08],0.44726063871991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.28 [0.68-2.43],0.447957228656237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLK4,Kallikrein-4,Inverse variance weighted,17,1.02 [0.96-1.09],0.45108948662977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.98 [0.94-1.03],0.451312067607575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.03 [0.96-1.1],0.455030824618043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,0.99 [0.95-1.02],0.459176547392749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.02 [0.98-1.06],0.459193820813339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.98 [0.91-1.04],0.464129359009277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.97 [0.91-1.04],0.467276834589305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.02 [0.97-1.06],0.472234035252924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN4,CCN family member 4,Inverse variance weighted,27,0.98 [0.94-1.03],0.472363944972437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.88 [0.62-1.25],0.476115973059372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.92 [0.72-1.17],0.477682754479337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.99 [0.96-1.02],0.478825312077808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.93-1.04],0.482463028088727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.07 [0.89-1.27],0.482468340698956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RTBDN,Retbindin,Inverse variance weighted,3,0.91 [0.7-1.18],0.482528908961954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.92 [0.74-1.16],0.48270584187497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHGA,Chromogranin-A,Inverse variance weighted,3,0.96 [0.85-1.08],0.484095804928052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.02 [0.97-1.08],0.486205885062928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REN,Renin,Inverse variance weighted,4,0.97 [0.89-1.06],0.493231481572878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.97 [0.89-1.06],0.4935321405935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.95 [0.8-1.11],0.49523166212227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.99 [0.95-1.02],0.499314564851455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.23 [0.67-2.26],0.49956396554475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.93 [0.77-1.14],0.499623633591843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.02 [0.97-1.07],0.500242617170489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.03 [0.95-1.12],0.507215347767838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.93 [0.76-1.15],0.508220643869687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPON1,Spondin-1,Inverse variance weighted,21,0.98 [0.91-1.05],0.509380462999928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.15 [0.75-1.77],0.527225010166926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.01 [0.98-1.03],0.527345188528868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.05 [0.9-1.23],0.528732188949684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.95 [0.83-1.1],0.530024470048205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.06 [0.89-1.25],0.530105726948646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.02 [0.96-1.07],0.536008885202671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.98 [0.93-1.04],0.539499427210109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.98 [0.93-1.04],0.541339347057525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.02 [0.95-1.11],0.542927442774296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.02 [0.95-1.11],0.547856342501934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.02 [0.96-1.08],0.547909540212083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.96 [0.84-1.1],0.548661077827203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OCLN,Occludin,Inverse variance weighted,2,0.93 [0.74-1.17],0.549709802715499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DPT,Dermatopontin,Inverse variance weighted,21,0.98 [0.92-1.04],0.552665706459796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PSAP,Prosaposin,Inverse variance weighted,5,1.04 [0.92-1.17],0.555395305570014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.02 [0.95-1.1],0.557686536321767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.03 [0.94-1.13],0.561288227123675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.87-1.08],0.562021075347352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.02 [0.95-1.1],0.568706668061972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1.01 [0.98-1.04],0.573961652390258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.01 [0.97-1.05],0.578874979016537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.99 [0.94-1.03],0.580125177920203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.15 [0.7-1.9],0.581849852167132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.02 [0.95-1.1],0.582951118272746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.97-1.02],0.583752266772275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.89 [0.58-1.36],0.586884782495228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,1.16 [0.68-1.99],0.589668857531369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.06 [0.86-1.31],0.591119149421157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.05 [0.87-1.28],0.593521763865348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,0.98 [0.91-1.06],0.594989021195427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.04 [0.9-1.21],0.596829890277044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.06 [0.85-1.31],0.606993918959828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,0.98 [0.91-1.06],0.615712006360689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.03 [0.93-1.13],0.616276061377863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.96 [0.81-1.13],0.622657492416663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.99 [0.96-1.03],0.624053090558897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.91 [0.62-1.33],0.629687544139297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.96 [0.81-1.14],0.633417348682103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.02 [0.95-1.08],0.638028749143478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.91 [0.6-1.37],0.640841805027735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.07 [0.81-1.42],0.642551475059797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.01 [0.97-1.05],0.653002470361315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN5,CCN family member 5,Inverse variance weighted,8,0.96 [0.8-1.15],0.656546540091756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.01 [0.95-1.08],0.658208375808307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGF,Placenta growth factor,Inverse variance weighted,2,0.88 [0.49-1.6],0.674903090184453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS1,Galectin-1,Inverse variance weighted,6,0.98 [0.91-1.06],0.676372242977296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.98 [0.9-1.07],0.676656267219483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.06 [0.8-1.42],0.676979832395986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.97-1.05],0.681016025105362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.97 [0.85-1.11],0.688707840498093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.03 [0.9-1.17],0.690884598154888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.95 [0.72-1.24],0.694493332967059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RSPO1,R-spondin-1,Inverse variance weighted,5,1.02 [0.93-1.12],0.701689628083745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.98 [0.91-1.07],0.703251599837798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.06 [0.8-1.4],0.704844202607905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.98 [0.89-1.09],0.705174791385587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.02 [0.91-1.15],0.70615818200234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.96 [0.76-1.21],0.707829418954963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BGLAP,Osteocalcin,Inverse variance weighted,2,0.93 [0.63-1.38],0.713221670168767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP7,Matrilysin,Inverse variance weighted,13,0.99 [0.93-1.05],0.716533455310611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP13,Collagenase 3,Inverse variance weighted,2,1.09 [0.69-1.7],0.717946510126728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.98 [0.89-1.09],0.718769746352423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CSTB,Cystatin-B,Inverse variance weighted,28,0.99 [0.95-1.04],0.732238425886844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.02 [0.93-1.12],0.733524073967429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALCA,Calcitonin,Inverse variance weighted,5,1.05 [0.8-1.36],0.736032644616737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.06 [0.74-1.53],0.738002325906408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VASN,Vasorin,Inverse variance weighted,14,0.99 [0.95-1.04],0.741686869332041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.01 [0.94-1.08],0.74420456580113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.09 [0.64-1.86],0.745037471301561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPPC,C-type natriuretic peptide,Wald ratio,1,1.1 [0.63-1.91],0.74634904169717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.04 [0.81-1.33],0.753634329693503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.09 [0.63-1.88],0.761280354729454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.99 [0.96-1.03],0.767786607678126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.01 [0.94-1.09],0.77348341802257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.99 [0.92-1.07],0.775309179308592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.02 [0.86-1.22],0.790678707235579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALB1,Calbindin,Inverse variance weighted,2,1.04 [0.79-1.35],0.793563074395067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD27,CD27 antigen,Inverse variance weighted,9,0.99 [0.93-1.06],0.796199442438728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.03 [0.82-1.3],0.802555314259867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MSLN,Mesothelin,Inverse variance weighted,25,1 [0.97-1.04],0.806614784279047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.95-1.04],0.807272653672318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.01 [0.94-1.09],0.808461941664995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.98 [0.8-1.19],0.814989328482073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.99 [0.92-1.07],0.817843851338704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.97 [0.73-1.28],0.818110355082745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PENK,Proenkephalin-A,Inverse variance weighted,19,0.99 [0.94-1.05],0.822419289848513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.94 [0.57-1.56],0.825138829621849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.01 [0.93-1.1],0.8272714624858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SDC1,Syndecan-1,Inverse variance weighted,2,1.02 [0.86-1.2],0.82944501765689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.98 [0.85-1.14],0.830525784013064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.99 [0.95-1.04],0.831863975574876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.99 [0.94-1.05],0.832033469469742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.99 [0.88-1.11],0.834156583027843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,1 [0.96-1.05],0.836551196797755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1 [0.95-1.04],0.838191374362019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.03 [0.8-1.32],0.839618792305889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.99 [0.88-1.11],0.841517745377618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD83,CD83 antigen,Inverse variance weighted,5,1.01 [0.9-1.14],0.842052082711825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AREG,Amphiregulin,Inverse variance weighted,3,0.98 [0.85-1.14],0.843078106018666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHGB,Secretogranin-1,Inverse variance weighted,27,1 [0.96-1.05],0.849062466007948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.01 [0.91-1.12],0.85114340749602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,APOA2,Apolipoprotein A-II,Wald ratio,1,0.97 [0.68-1.37],0.854738324664385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THBD,Thrombomodulin,Inverse variance weighted,5,1.01 [0.9-1.13],0.858225305530333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.07 [0.5-2.27],0.86153121393902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RSPO3,R-spondin-3,Inverse variance weighted,6,0.99 [0.88-1.12],0.86569613915242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD160,CD160 antigen,Inverse variance weighted,11,0.99 [0.92-1.07],0.869616940968126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.01 [0.92-1.11],0.869838619524983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FBLN2,Fibulin-2,Inverse variance weighted,11,1.01 [0.95-1.07],0.871445264148546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.01 [0.86-1.19],0.871890241728318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1 [0.95-1.04],0.873951188664174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.96-1.04],0.876261161839308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.01 [0.87-1.17],0.877778304836504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.97 [0.69-1.38],0.878327114924271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.98 [0.76-1.26],0.87996998334724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.01 [0.91-1.12],0.892159482873346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.01 [0.88-1.16],0.892387317507145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PI3,Elafin,Inverse variance weighted,10,0.99 [0.92-1.07],0.892712728964027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NECTIN4,Nectin-4,Inverse variance weighted,7,1 [0.94-1.08],0.897044279226273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MDK,Midkine,Inverse variance weighted,4,0.98 [0.76-1.27],0.901584341721277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VIT,Vitrin,Inverse variance weighted,25,1 [0.96-1.03],0.901594445628226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1 [0.97-1.03],0.902980680998962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,1 [0.95-1.05],0.904177569600054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1 [0.94-1.07],0.904669661997489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.01 [0.88-1.15],0.906590827775038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH1,Cadherin-1,Wald ratio,1,0.97 [0.59-1.6],0.908030077604383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.01 [0.87-1.17],0.910224309361978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD302,CD302 antigen,Inverse variance weighted,9,0.99 [0.88-1.12],0.910803199664211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.04 [0.54-2.01],0.912716003739697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1 [0.94-1.07],0.913944226810196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1 [0.92-1.1],0.91407403552554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1 [0.96-1.05],0.917032264435398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.99 [0.89-1.11],0.920983163757371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PLIN3,Perilipin-3,Wald ratio,1,0.98 [0.71-1.36],0.921885979994142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.96-1.04],0.924315839668755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1 [0.92-1.08],0.930066735650103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.01 [0.88-1.15],0.930862511490893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANXA10,Annexin A10,Wald ratio,1,0.98 [0.62-1.55],0.935295262414089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.01 [0.86-1.18],0.935478421231031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.01 [0.8-1.27],0.935791140859214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1 [0.9-1.12],0.937265626411796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1 [0.94-1.07],0.937549301659021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.99 [0.82-1.2],0.938167192420305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.93-1.07],0.941679053114219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANG,Angiogenin,Inverse variance weighted,19,1 [0.95-1.05],0.953322542138211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AGRN,Agrin,Inverse variance weighted,17,1 [0.93-1.07],0.953723089629144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1 [0.93-1.07],0.961961754163102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL15,Interleukin-15,Wald ratio,1,1.05 [0.12-9.18],0.965435628642352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1 [0.83-1.2],0.969820205246827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1 [0.78-1.29],0.970703592797971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP3,Stromelysin-1,Inverse variance weighted,34,1 [0.95-1.05],0.980590734144108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1 [0.94-1.06],0.98338072450295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1 [0.94-1.06],0.986444328484017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1 [0.87-1.15],0.988403869934659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1 [0.94-1.06],0.990599411473343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD59,CD59 glycoprotein,Inverse variance weighted,4,1 [0.86-1.16],0.993704738102361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1 [0.89-1.13],0.994557805166428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1 [0.94-1.07],0.994849538827101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1 [0.95-1.05],0.994887315012194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1 [0.93-1.08],0.995834038972401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CFD,Complement factor D,Inverse variance weighted,11,1 [0.92-1.08],0.999587927467626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.78 [0.67-0.9],0.000807901007913502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.35 [1.12-1.62],0.00128222573966075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.47 [0.29-0.75],0.00142789567478806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGF,Placenta growth factor,Inverse variance weighted,5,0.75 [0.62-0.91],0.00285255296712087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS9,Galectin-9,Inverse variance weighted,36,1.07 [1.02-1.12],0.00427644822044179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.39 [1.1-1.77],0.00629093635765876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.14 [1.03-1.27],0.00910152736072554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD27,CD27 antigen,Inverse variance weighted,9,0.79 [0.66-0.94],0.00985280988984634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.75 [0.6-0.94],0.0117727592404622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.46 [1.09-1.95],0.012167851077273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.69 [0.52-0.93],0.014423539345757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.77 [0.62-0.95],0.0156153330325294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DRAXIN,Draxin,Inverse variance weighted,25,1.13 [1.02-1.25],0.0185145295360725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THBD,Thrombomodulin,Inverse variance weighted,11,1.11 [1.02-1.2],0.0198281362093882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.04 [1.01-1.08],0.0207557854073983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MDK,Midkine,Inverse variance weighted,14,0.87 [0.77-0.98],0.0237203634001697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PALM2,Paralemmin-2,Inverse variance weighted,9,1.11 [1.01-1.22],0.025007388409456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.17 [1.02-1.35],0.0286430759825694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,24,0.89 [0.8-0.99],0.0303626998771049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.8 [0.65-0.98],0.0312596605870078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.1 [1.01-1.21],0.0321714735282037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.08 [1.01-1.16],0.0345064186677783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.86 [0.74-0.99],0.0350842256484469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.4 [1.02-1.92],0.037933178477752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTH,Parathyroid hormone,Inverse variance weighted,11,1.13 [1-1.27],0.0430088348188766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.15 [1-1.32],0.0453702165062242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.72 [0.52-0.99],0.0456463217013575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.08 [1-1.17],0.0466445117425606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REN,Renin,Inverse variance weighted,8,0.84 [0.71-1],0.0471535878137454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.16 [0.99-1.36],0.0579880126232682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.07 [1-1.15],0.064190108415062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRSS2,Trypsin-2,Inverse variance weighted,17,1.1 [0.99-1.21],0.0656992446245478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.58 [0.97-2.58],0.0669099917772704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.13 [0.99-1.3],0.0672099461233688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.68 [0.96-2.96],0.0714493056670361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PSAP,Prosaposin,Inverse variance weighted,13,1.07 [0.99-1.16],0.0734497289590379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.9 [0.8-1.01],0.0828070548574248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.86 [0.72-1.02],0.0857654445328155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.17 [0.97-1.41],0.0919287557872537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD99,CD99 antigen,Inverse variance weighted,4,0.84 [0.69-1.03],0.0932290022698293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.16 [0.97-1.39],0.101171281261029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.21 [0.96-1.52],0.105939694814249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDHR1,Cadherin-related family member 1,Inverse variance weighted,19,1.06 [0.99-1.14],0.107406906730231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.13 [0.97-1.31],0.112437227157661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.3 [0.93-1.8],0.121765286056653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.04 [0.99-1.1],0.121779419232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OGN,Mimecan,Inverse variance weighted,37,0.96 [0.91-1.01],0.122562859739252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL17C,Interleukin-17C,Inverse variance weighted,5,0.83 [0.65-1.05],0.123552126853159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WNT9A,Protein Wnt-9a,Wald ratio,1,1.66 [0.87-3.18],0.127101854093228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,1.04 [0.99-1.09],0.133391232931758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.08 [0.97-1.21],0.139396929929296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.76 [0.52-1.1],0.139670743945431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH6,Cadherin-6,Inverse variance weighted,5,1.19 [0.94-1.5],0.143288221406714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.06 [0.98-1.14],0.145783778050168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.11 [0.96-1.27],0.146293579230809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.92 [0.83-1.03],0.148256456179921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.89 [0.75-1.04],0.149370390772527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.91 [0.79-1.04],0.150757271521031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AMBP,Protein AMBP,Inverse variance weighted,5,1.12 [0.96-1.31],0.151707048576538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.89 [0.77-1.04],0.156282536247612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CST3,Cystatin-C,Inverse variance weighted,3,1.25 [0.91-1.71],0.164167775857848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.43 [0.86-2.39],0.166265786435881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.11 [0.96-1.29],0.166610144239723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.09 [0.96-1.22],0.170180540212162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DPT,Dermatopontin,Inverse variance weighted,4,0.83 [0.62-1.09],0.180567258155875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.03 [0.98-1.09],0.180652057927149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.96 [0.91-1.02],0.183012090534246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.97 [0.92-1.02],0.188347030647318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRL,Prolactin,Inverse variance weighted,7,1.21 [0.91-1.61],0.188728394055502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.89 [0.74-1.06],0.189634995814284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.93-1.01],0.191649973340306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.89 [0.75-1.06],0.196462924041017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AREG,Amphiregulin,Inverse variance weighted,5,1.15 [0.93-1.41],0.200196923099726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.08 [0.96-1.22],0.204274235708376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.36 [0.84-2.19],0.206317529039958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.02 [0.99-1.06],0.208071393755666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RSPO3,R-spondin-3,Inverse variance weighted,5,1.13 [0.93-1.38],0.218217438758846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD302,CD302 antigen,Inverse variance weighted,11,1.09 [0.95-1.24],0.219065363741638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN3,CCN family member 3,Inverse variance weighted,17,0.96 [0.89-1.03],0.219323089431706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.86 [0.67-1.1],0.220436090341804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.11 [0.94-1.32],0.220436546787049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OCLN,Occludin,Inverse variance weighted,2,1.22 [0.88-1.69],0.2243749144355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.19 [0.9-1.56],0.224427547962405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.06 [0.96-1.17],0.224900829837672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLK11,Kallikrein-11,Inverse variance weighted,13,0.93 [0.83-1.05],0.234798650195331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.09 [0.94-1.27],0.238543291065005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.93 [0.81-1.05],0.243786536465234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.19 [0.89-1.61],0.244480884776635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.81 [0.57-1.16],0.246528239223879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.8 [0.55-1.17],0.254902230667536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.12 [0.92-1.36],0.256312457205344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.84 [0.62-1.13],0.257758360644078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.19 [0.88-1.61],0.268785893794015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.11 [0.92-1.34],0.270403023300979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.09 [0.93-1.27],0.276031150111604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.86 [0.65-1.13],0.282108952217231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.04 [0.97-1.12],0.283747126290387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.28 [0.81-2],0.286839345596507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ELN,Elastin,Inverse variance weighted,10,1.09 [0.93-1.27],0.287084794121705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.19 [0.86-1.65],0.287845816741779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.12 [0.9-1.39],0.294210250404318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.86 [0.65-1.14],0.294769404264528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.09 [0.93-1.28],0.29775097613889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.07 [0.94-1.22],0.2987641989901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.92 [0.8-1.07],0.301121932875244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CFD,Complement factor D,Wald ratio,1,1.29 [0.79-2.11],0.302793220695508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS4,Galectin-4,Inverse variance weighted,15,0.96 [0.9-1.03],0.303830859140363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.88 [0.69-1.12],0.306291896340484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.1 [0.92-1.32],0.308733455445894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.95-1.02],0.312050788677649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.76 [0.45-1.29],0.313269762285003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SDC1,Syndecan-1,Inverse variance weighted,12,0.94 [0.83-1.06],0.315675369927487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.07 [0.94-1.23],0.315895816248953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.88 [0.67-1.14],0.323539735434043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDH12,Protocadherin-12,Inverse variance weighted,6,1.13 [0.88-1.45],0.324471429356212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.15 [0.87-1.54],0.325843782741343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALCA,Calcitonin,Inverse variance weighted,13,1.1 [0.91-1.34],0.330243448573147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.08 [0.92-1.27],0.33044047983946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PALM,Paralemmin-1,Inverse variance weighted,4,0.83 [0.58-1.2],0.330558833209263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.87 [0.65-1.16],0.331961251020478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.95 [0.86-1.05],0.337893913229713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VIT,Vitrin,Inverse variance weighted,10,1.09 [0.91-1.3],0.338892114405643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.96-1.14],0.341935502233082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.7 [0.33-1.47],0.345767659200811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.99 [0.96-1.01],0.346552058137427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.96 [0.87-1.05],0.348547757068517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LMNB2,Lamin-B2,Inverse variance weighted,8,1.09 [0.91-1.32],0.349438856993842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.18 [0.83-1.69],0.353839808005999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.95 [0.84-1.06],0.354402799941826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.76 [0.42-1.36],0.357270489707316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.13 [0.86-1.49],0.365550224158449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.85 [0.6-1.21],0.365864101762844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.04 [0.95-1.15],0.367741585065386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.05 [0.94-1.18],0.370721915011692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.84 [0.57-1.23],0.373338886514772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1.01 [0.99-1.04],0.373542012590498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.88 [0.66-1.17],0.373705245023497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.98 [0.93-1.03],0.374699689409925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DSC2,Desmocollin-2,Inverse variance weighted,16,0.96 [0.88-1.05],0.376158481389272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.9 [0.7-1.15],0.380637931415746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.08 [0.91-1.27],0.382989618114409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.04 [0.95-1.14],0.384590334723433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.88 [0.65-1.18],0.385395501291386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.08 [0.9-1.3],0.387271325096847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.98-1.05],0.389047876689165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.9 [0.7-1.15],0.389940047106204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CFC1,Cryptic protein,Inverse variance weighted,11,1.07 [0.92-1.23],0.395166334470642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.17 [0.81-1.69],0.39524139875012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.96 [0.87-1.06],0.401313461368774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.85 [0.59-1.24],0.403650512980696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.11 [0.87-1.41],0.404130952371023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.95 [0.84-1.07],0.407481007811179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.92 [0.74-1.13],0.412890868432293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.9 [0.7-1.16],0.415199092475196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RGMB,RGM domain family member B,Inverse variance weighted,5,0.9 [0.71-1.16],0.423002811864674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.05 [0.93-1.18],0.430285502342649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.15 [0.81-1.63],0.433381479699629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.23 [0.73-2.05],0.438889401617561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,1.15 [0.81-1.64],0.442524884879397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGA4,Pepsin A-4,Inverse variance weighted,7,1.07 [0.9-1.28],0.443506984141837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.13 [0.83-1.53],0.444313053690125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.92 [0.73-1.15],0.446148060157414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.94 [0.81-1.1],0.454866956087653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.04 [0.94-1.15],0.457708525341642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.1 [0.86-1.41],0.459787432069528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.02 [0.96-1.1],0.472218174046454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TSHB,Thyrotropin subunit beta,Inverse variance weighted,31,1.02 [0.96-1.1],0.47409236559004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.94 [0.79-1.12],0.481021106619352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.92 [0.74-1.15],0.483561285112086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANG,Angiogenin,Inverse variance weighted,8,0.93 [0.75-1.15],0.48529815153504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEPTIN8,Septin-8,Inverse variance weighted,4,0.88 [0.62-1.25],0.485739688470793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.18 [0.75-1.85],0.486007688313111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.04 [0.93-1.18],0.487482308421445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.94 [0.8-1.11],0.488103647821321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.09 [0.85-1.39],0.490464354154334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.97 [0.88-1.06],0.493903116245429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.93 [0.75-1.15],0.496494016878359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.95 [0.8-1.11],0.497163755778862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.21 [0.7-2.1],0.498049904171683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.04 [0.93-1.17],0.500141570924027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.05 [0.91-1.2],0.500411617278882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.08 [0.86-1.36],0.500784323744536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.26 [0.64-2.49],0.500953566360565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,0.92 [0.73-1.16],0.503055085662604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,POF1B,Protein POF1B,Inverse variance weighted,4,0.93 [0.76-1.14],0.503740649411555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.95 [0.83-1.1],0.504162972086153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.92 [0.72-1.17],0.504594987832035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.07 [0.87-1.31],0.517879471194546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BSG,Basigin,Inverse variance weighted,6,1.1 [0.83-1.46],0.517952899700471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.04 [0.91-1.19],0.5196177111694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.02 [0.97-1.07],0.520913460594242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.07 [0.87-1.3],0.52687529925644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.77-1.14],0.530435000130365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NECTIN4,Nectin-4,Inverse variance weighted,4,0.92 [0.7-1.2],0.532140776781084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.95 [0.79-1.13],0.538648144508665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRSS8,Prostasin,Inverse variance weighted,14,0.96 [0.83-1.1],0.543415147377071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.02 [0.96-1.07],0.545053364346006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ALCAM,CD166 antigen,Inverse variance weighted,4,0.93 [0.74-1.17],0.546365545438156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.04 [0.92-1.18],0.546756182649975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.93 [0.75-1.17],0.555386904225508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.03 [0.93-1.15],0.556153370427461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH15,Cadherin-15,Inverse variance weighted,4,0.92 [0.69-1.22],0.561099508291531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.76 [0.3-1.92],0.561952394721434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,XG,Glycoprotein Xg,Inverse variance weighted,2,0.84 [0.45-1.54],0.56282922342614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAYN,Layilin,Inverse variance weighted,3,0.91 [0.66-1.25],0.567145455391945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.9 [0.62-1.3],0.570053249312668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.94 [0.76-1.16],0.572542985980474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.93 [0.74-1.19],0.572856077673129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.03 [0.94-1.12],0.573137480762805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSV,Cathepsin L2,Inverse variance weighted,34,0.98 [0.93-1.04],0.573332531523103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.06 [0.86-1.32],0.578504994053121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.99 [0.94-1.04],0.581235702014438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.96 [0.83-1.11],0.587862743819471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.05 [0.89-1.23],0.590354627197457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.97 [0.86-1.09],0.591325705884346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AGRN,Agrin,Inverse variance weighted,14,0.96 [0.82-1.12],0.594665079581836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.95-1.03],0.599975474547025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.06 [0.86-1.3],0.606740634530234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.05 [0.88-1.24],0.616442964566357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.14 [0.68-1.91],0.617892634373138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN4,CCN family member 4,Inverse variance weighted,29,0.99 [0.94-1.04],0.620411666294529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.98 [0.92-1.05],0.620755566331856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.03 [0.91-1.16],0.627043717408636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.03 [0.92-1.15],0.629859616202322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MSLN,Mesothelin,Inverse variance weighted,11,0.97 [0.85-1.1],0.632520625936961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PENK,Proenkephalin-A,Inverse variance weighted,15,1.02 [0.93-1.12],0.633541812615997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.18 [0.6-2.33],0.633987289212319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.04 [0.9-1.2],0.638504062588561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.03 [0.9-1.19],0.638964855590908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RETN,Resistin,Inverse variance weighted,19,1.03 [0.92-1.14],0.640187763006488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPP1,Osteopontin,Inverse variance weighted,13,1.03 [0.9-1.19],0.642255470432556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH1,Cadherin-1,Inverse variance weighted,16,0.98 [0.91-1.06],0.642334679554863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NECTIN2,Nectin-2,Inverse variance weighted,3,0.92 [0.63-1.33],0.642604305147862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPON1,Spondin-1,Inverse variance weighted,4,1.08 [0.78-1.49],0.644477077930065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.06 [0.84-1.33],0.648020569140322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,UMOD,Uromodulin,Inverse variance weighted,34,0.98 [0.9-1.07],0.648096311209222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.97 [0.84-1.12],0.64815217372403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.07 [0.79-1.45],0.657013555234638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.02 [0.93-1.12],0.657714767821207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BGLAP,Osteocalcin,Inverse variance weighted,8,0.96 [0.81-1.14],0.659267851763202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.96-1.06],0.659377190508369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.02 [0.94-1.09],0.660049918951493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RSPO1,R-spondin-1,Inverse variance weighted,8,0.97 [0.85-1.11],0.660163982718875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.97 [0.82-1.13],0.664638354198866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP13,Collagenase 3,Wald ratio,1,0.89 [0.54-1.48],0.665250148720116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.03 [0.89-1.2],0.665933926513525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.03 [0.9-1.18],0.670446604338119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP3,Stromelysin-1,Inverse variance weighted,4,1.07 [0.79-1.45],0.677392282564165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLK4,Kallikrein-4,Inverse variance weighted,5,0.94 [0.7-1.26],0.678722615195532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.07 [0.78-1.47],0.681545429586834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,0.98 [0.9-1.07],0.685539531813754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP10,Stromelysin-2,Wald ratio,1,0.89 [0.49-1.59],0.686432031973196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GUCA2A,Guanylin,Inverse variance weighted,7,1.03 [0.88-1.22],0.687289578687999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.02 [0.91-1.16],0.68938148968882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL6,Interleukin-6,Inverse variance weighted,6,0.98 [0.89-1.08],0.692470960993007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.03 [0.89-1.2],0.693566555675143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VWC2,Brorin,Inverse variance weighted,12,1.04 [0.86-1.25],0.69924367659079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VASN,Vasorin,Inverse variance weighted,5,1.07 [0.75-1.53],0.6997114528588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.04 [0.86-1.26],0.700149097259174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.04 [0.85-1.28],0.70111690782188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.98 [0.89-1.08],0.70319943030445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.9 [0.51-1.58],0.704587797488358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.05 [0.83-1.32],0.704948545917892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.97-1.05],0.705286824465253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.08 [0.73-1.6],0.705958560498519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.03 [0.89-1.2],0.709434201884312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CSTB,Cystatin-B,Inverse variance weighted,23,0.99 [0.94-1.04],0.718984105977076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.04 [0.82-1.33],0.721857920236446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.03 [0.89-1.18],0.724154325496817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.95 [0.71-1.27],0.724882166863393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.04 [0.84-1.28],0.725993717724964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.96 [0.75-1.22],0.726066908566182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.07 [0.73-1.56],0.727857386546236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.99 [0.96-1.03],0.733602429191005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCG2,Secretogranin-2,Inverse variance weighted,2,1.05 [0.79-1.41],0.735443241594592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GAST,Gastrin,Inverse variance weighted,9,0.98 [0.85-1.12],0.742156792386311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHGB,Secretogranin-1,Inverse variance weighted,7,0.97 [0.81-1.16],0.742794544251951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.04 [0.83-1.29],0.745797552453172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.03 [0.88-1.2],0.747123309855323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN5,CCN family member 5,Inverse variance weighted,12,1.01 [0.93-1.1],0.748875820763764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.94 [0.64-1.37],0.74953168390532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.02 [0.92-1.11],0.751084075847023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NRP2,Neuropilin-2,Inverse variance weighted,14,1.02 [0.9-1.16],0.751447791971773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.1 [0.61-1.98],0.756689265943399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.02 [0.89-1.17],0.760761506267245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.92-1.06],0.76682470090411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CX3CL1,Fractalkine,Inverse variance weighted,12,0.98 [0.85-1.12],0.76732089234326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.98 [0.85-1.13],0.768715737756164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.86-1.12],0.776081919336553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.02 [0.87-1.2],0.781688476411437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.96 [0.7-1.31],0.78179644154344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.97 [0.81-1.18],0.783062780556629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,0.97 [0.76-1.23],0.783112989536374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.03 [0.84-1.26],0.784833642497489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,1.05 [0.74-1.5],0.789661195039284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.04 [0.76-1.42],0.794246152372082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.03 [0.82-1.29],0.795549110859356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.92-1.06],0.80014036028547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.94 [0.59-1.51],0.803382103269152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD276,CD276 antigen,Inverse variance weighted,24,1.01 [0.94-1.09],0.811769279708661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.03 [0.81-1.3],0.813647761800789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.01 [0.95-1.07],0.815181959756359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.03 [0.78-1.37],0.81678110289577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RTBDN,Retbindin,Inverse variance weighted,2,0.97 [0.71-1.31],0.82340449797027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.99 [0.92-1.07],0.828585415967619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.02 [0.86-1.21],0.830476080484728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.02 [0.83-1.25],0.837930016503653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL19,Interleukin-19,Inverse variance weighted,10,0.99 [0.93-1.06],0.839000805980769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.97 [0.75-1.26],0.839344120004435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.99 [0.87-1.12],0.840051365785171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.04 [0.74-1.45],0.842391044224685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.99 [0.87-1.12],0.844054090420218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.04 [0.69-1.58],0.847611678246831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.04 [0.68-1.61],0.84817078079489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.02 [0.84-1.23],0.854003763511862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FBLN2,Fibulin-2,Inverse variance weighted,6,0.98 [0.75-1.26],0.85488881604771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.02 [0.82-1.27],0.859958909203733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.99 [0.92-1.08],0.861225785268787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.95-1.06],0.86614957220058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.01 [0.94-1.08],0.868816652904485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.95-1.05],0.871716203426268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPON2,Spondin-2,Inverse variance weighted,3,0.97 [0.71-1.33],0.873739193661787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PPL,Periplakin,Inverse variance weighted,2,1.02 [0.75-1.39],0.882981350347162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,0.96 [0.52-1.75],0.884977159359677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.97 [0.65-1.45],0.888233942002757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MB,Myoglobin,Inverse variance weighted,9,0.98 [0.79-1.23],0.891704795902961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSL,Cathepsin L1,Inverse variance weighted,29,1.01 [0.92-1.1],0.893878097434801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD160,CD160 antigen,Inverse variance weighted,24,0.99 [0.89-1.11],0.89552044550582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.99 [0.87-1.13],0.898638085278662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.03 [0.67-1.57],0.898811068139622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1 [0.96-1.04],0.899876466612572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.98 [0.72-1.34],0.900041413557439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,0.99 [0.91-1.09],0.910012675893624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.04 [0.51-2.13],0.912105111245729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.01 [0.91-1.1],0.912311682094664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHGA,Chromogranin-A,Inverse variance weighted,5,0.99 [0.81-1.21],0.914243201385506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1 [0.93-1.08],0.919674473848355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.01 [0.87-1.16],0.919709489877549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1 [0.92-1.1],0.92135791116465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.01 [0.8-1.27],0.921372131163497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP7,Matrilysin,Wald ratio,1,0.99 [0.8-1.22],0.921623998269214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1 [0.95-1.06],0.923158779021761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LMOD1,Leiomodin-1,Inverse variance weighted,6,1 [0.9-1.12],0.92746113822853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD83,CD83 antigen,Inverse variance weighted,14,0.99 [0.87-1.14],0.927868024436088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP6,Gastrotropin,Inverse variance weighted,4,0.99 [0.76-1.29],0.92849900781144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1 [0.96-1.04],0.930804865529004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1 [0.96-1.04],0.932379446462953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1 [0.92-1.1],0.932799808110264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.01 [0.87-1.16],0.936400764681892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.01 [0.78-1.31],0.936566586017257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.01 [0.69-1.48],0.938978842027449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.01 [0.73-1.4],0.942102630260155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.99 [0.7-1.39],0.943472918820082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.01 [0.75-1.36],0.952360379441308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.01 [0.75-1.36],0.954911214011503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.01 [0.8-1.27],0.95564258590547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1 [0.88-1.14],0.971967092696466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1 [0.77-1.3],0.975585703665697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1 [0.77-1.3],0.980033792556063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALB1,Calbindin,Inverse variance weighted,9,1 [0.87-1.14],0.980360485087115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1 [0.82-1.22],0.982212510865949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1 [0.73-1.37],0.986152699975349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PI3,Elafin,Inverse variance weighted,18,1 [0.94-1.07],0.988095624179524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1 [0.7-1.43],0.992347962266027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1 [0.8-1.25],0.994710933575168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COLEC12,Collectin-12,Inverse variance weighted,3,1 [0.72-1.38],0.997872785275889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH3,Cadherin-3,Inverse variance weighted,10,1 [0.77-1.29],0.999230946760153,trans
